WVCI research updates
Widely regarded for our research, our work and additional information about clinical trials frequently appears in news media, trade publications, journals, presentations, and on our blog.
Hard-to-treat cancer responds to clinical trial drug
As reported by The Register-Guard, lung cancer patient Doug Penn’s inoperable tumor has been shrinking during his participation in one of our clinical trials. He is one of six patients at WVCI who is participating in this study. Read more here.
FDA fast-tracks new drug for leukemia patients
As reported by KMTR NewsSource 16: Oncologist Dr. Jeff Sharman talks about clinical trials for the drug Gazyva, and how the results led to FDA breakthrough status for the drug in its treatment of chronic lymphocytic leukemia (CLL). See the video story here.
Teaching the immune system to recognize cancer cells
As reported by KEZI-9News: The clinical trial medicine, Gazyva, gives CLL cancer patient, Betty Hemmingsen a new lease on life. Dr. Jeff Sharman talks about how the breakthrough drug supports the immune’s system ability to fight cancer, without the side effects of traditional chemotherapy. See the video story here.
News highlights research, services and support at WVCI
Reported by The Register-Guard, this news article highlights our breakthrough treatments and features WVCI’s Dr. Jeff Sharman, an internationally recognized expert on chronic lymphocytic leukemia (CLL). Read the full story here.
Clinical trials offer life-saving options for cancer patients
As reported by KMTR NewsSource 16: As researchers test the effectiveness of the trial drugs, patients who participate, in many cases, benefit from life-saving treatment options years before they are available to the public. Read more.
Oncologists’ national appointment means greater support for local lymphoma and leukemia patients
WVCI’s Dr. Jeff Sharman was recently appointed associate chair of blood cancer research for US Oncology, the nation’s premier oncology services company. By accepting this national appointment, those in Lane County will now have greater access to lymphoma and leukemia drugs through clinical trials, offering new hope for patients right here in our community. Read more.
Personalized medicine means better drugs, fewer side effects
By targeting specific gene mutations, doctors can now use personalized medicine to treat cancer based upon unique features that caused it to grow. Medical oncologist Dr. Jeff Sharman is helping lead the way in personalized medicine through research and clinical trials at Willamette Valley Cancer Institute and Research Center. Read more.